Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.44 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.42 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1160889 | 1.00 | CYP2D6 (0.48) | CYP2D6HTR2ATAAR1SLC6A2SIGMAR1 | |
| SCHEMBL6314764 | 0.87 | CYP2D6 (0.43) | CYP2D6TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL23457325 | 0.87 | SMN1; SMN2 (0.37) | CYP2D6HTR2ATAAR1SLC6A2SIGMAR1 | |
| SCHEMBL6546687 | 0.83 | L3MBTL1 (0.47) | HTR2ATAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL10599552 | 0.82 | SIGMAR1 (0.52) | CYP2D6TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL21471624 | 0.82 | L3MBTL1 (0.46) | CYP2D6HTR2ATAAR1SIGMAR1MAOA | |
| Hydrogen Peroxide SCHEMBL29140083 | 0.82 | L3MBTL1 (0.50) | HTR2ASLC6A2L3MBTL1CALM1BCL2 | |
| SCHEMBL9113255 | 0.80 | L3MBTL1 (0.49) | HTR2ATAAR1L3MBTL1CALM1BCL2 | |
| SCHEMBL27428238 | 0.80 | L3MBTL1 (0.49) | HTR2ATAAR1L3MBTL1CALM1BCL2 | |
| SCHEMBL27683376 | 0.79 | HTR2A (0.47) | HTR2ATAAR1SLC6A2SIGMAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3807294-B1 | PEPTIDES HAVING INHIBITORY ACTIVITY ON MUSCARINIC RECEPTOR M3 | ACRAF (IT) | 2026-01-14 | — | — | EP | claimed |
| EP-3807293-B1 | PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS | ACRAF (IT) | 2026-01-14 | — | — | EP | claimed |
| US-20230372492-A1 | DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME | MISSISSIPPI STATE UNIVERSITY (US) | 2023-11-23 | — | — | US | claimed |
| EP-4221755-A1 | DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME | Mississippi State University (US) | 2023-08-09 | — | — | EP | claimed |
| WO-2022072425-A1 | DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME | PARK JOO YOUN (US) | 2022-04-07 | — | — | WO | claimed |
| CN-107474208-B | A kind of multi-functional benzoxazine composite material and preparation method | 四川天策聚材科技有限公司 | 2019-10-22 | — | — | CN | claimed |
| CN-110156982-A | A kind of liquid liquid homogeneous method using continuous flow micro passage reaction synthesis polyarylether | 常州中英新材料有限公司 | 2019-08-23 | — | — | CN | claimed |
| CN-110156983-A | Liquid-liquid heterogeneous method for synthesizing polyarylether by using continuous flow microchannel reactor | 常州中英新材料有限公司 | 2019-08-23 | — | — | CN | claimed |
| CN-104628892-B | Preparation method and use of 6-benzyl phenylethylamine derivative beta-cyclodextrin bonded SBA-15 | 南昌大学 | 2017-02-22 | — | — | CN | claimed |
| CN-106397273-A | Improved preparation method of sacubitril intermediate | 四川海思科制药有限公司 | 2017-02-15 | — | — | CN | claimed |
| EP-2207776-B9 | DRUG ACTIVE IN NEUROPATHIC PAIN | ACRAF (IT) | 2016-12-21 | — | — | EP | claimed |
| EP-2207776-B1 | DRUG ACTIVE IN NEUROPATHIC PAIN | ACRAF (IT) | 2016-08-17 | — | — | EP | claimed |
| CN-104628892-A | Preparation method and use of 6-benzyl phenylethylamine derivative beta-cyclodextrin bonded SBA-15 | UNIV NANCHANG | 2015-05-20 | — | — | CN | claimed |
| EP-1017358-B1 | REDUCTION OF HAIR GROWTH | GILLETTE CO (US) | 2004-08-11 | — | — | EP | claimed |
| EP-3807294-A1 | PEPTIDES HAVING INHIBITORY ACTIVITY ON MUSCARINIC RECEPTOR M3 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. (IT) | 2021-04-21 | — | — | EP | disclosed |
| EP-3807293-A1 | PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. (IT) | 2021-04-21 | — | — | EP | disclosed |
| WO-2019238686-A1 | PEPTIDES HAVING INHIBITORY ACTIVITY ON MUSCARINIC RECEPTOR M3 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.P.A. (IT) | 2019-12-19 | — | — | WO | disclosed |
| US-20040067981-A1 | Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants | SANKYO COMPANY, LIMITED (JP) | 2004-04-08 | — | — | US | disclosed |
| EP-1362844-A1 | BENZYLAMINE ANALOGUE | Sankyo Company, Limited (JP) | 2003-11-19 | — | — | EP | disclosed |
| EP-0429149-A1 | Tricyclic pteridinones and a process for their preparation | BERLEX LABORATORIES, INC. (US) | 1991-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372492-A1 | DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME | GFPT1, PHPT1, SLC2A1 | CYP2D6 255/4885HTR2A 2919/4885TAAR1 4381/4885 |
| US-20040067981-A1 | Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants | ACHE, BACE1, CHRNA6 | CYP2D6 613/4885HTR2A 97/4885TAAR1 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.